Presentations in Plenary 2018
Plenary Session 1: A Visionary Outlook
This session drew the broad picture of why this summit was neeeded; the challenges ahead, including those from an equity of access and economic perspective. It also shed light on the many opportunities, for example in bio-banks, data and registries that can create a positive trajectory forward.
Speakers:
- Dr. Susan Galbraith, Head of Oncology, iMed, Innovative Medicines, AstraZeneca
Please find the video presentation here. - Professor Klas Kärre, Chairman, the Swedish Cancer Society’s research committee
Please find the video presentation here. - Professor Max Parkin, Nuffield Dept. of Population Health, Oxford University
Please find the video presentation here.
Plenary Session 2: Patients as a driving force to develop care
In many parts of the world, patients and their kin claim an individual relation to healthcare, focusing on the patient. Expectations are high on receiving an individualized treatment; on transparency and on access to your own data. Many also want to contribute to the development of cancer care with their own data, generated inside or outside healthcare.
How will this development influence the relationship between healthcare and the individual patient? How can healthcare take advantage of the research advancements in precision medicine? How should patients be involved? And is a patient focus only a high income luxury or a possibility everywhere?
Speakers:
- Gregory C. Simon J.D., President, Biden Cancer Initiative
Please find the video presentation here. - Dr. Ingela Franck Lissbrant, MD, PhD, Sahlgrenska University Hospital and Swedish National Prostate Cancer Registry
Please find the video presentation here. - Marie Ennis O'Connor, Patient Empowerment Foundation and Health Care Social Media.
Please find the video presentation here. - Kelechi Eguzo, MD, MPH, Nigerian Christian Hospital; Chairman Marjorie Bash Foundation, Nigeria
Please find the video presentation here.
Plenary session 3: Access to treatments and diagnostics
Access to new cancer diagnostics and treatments is extremely unequally distributed, especially between high- and low income countries. Pharma industry has been strongly criticized for charging too much. But is it really that simple? Can we secure both access and an innovating industry?
Speakers:
- Dr. Mariângela Simão, WHO, Assistant Director General
Please find the video presentation here. - Professor Arnie Purushotham, King's College London and Tata Trust, Mumbai
Please find the video presentation here. - Thomas B. Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Please find the video presentation here.
Plenary Session 4: The threats against public health - Governance versus behavioural changes
Lifestyle is responsible for 30 % of all cancer cases. Tobacco alone may explain 20 %. Is it responsible to lay the burden of changing lifestyle on the individual only? What can can international governance and politics achieve?
Speakers:
- Dr. Vinayak Mohan Prasad, Programme Manager, Tobacco Control, WHO
- Professor Mike Kelly, Institute of Public Health, University of Cambridge
- Professor Emerita Barbro Westerholm, Member of Swedish Parliament
- Professor Folke Tersman, Department of Philosophy, Uppsala University